Patents by Inventor Surendra Chavan

Surendra Chavan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF MODULATING THE NEGATIVE CHEMOTAXIS OF IMMUNE CELLS
    Publication number: 20160199470
    Abstract: The current invention is directed to methods of inducing migration of an immune cell toward a cancer cell comprising inhibiting the activity of a chemorepellant released from the cancer cell.
    Type: Application
    Filed: January 8, 2016
    Publication date: July 14, 2016
    Inventors: Surendra Chavan, Jonathan L. Moon, Lopa Bhatt
  • METHODS OF MODULATING THE NEGATIVE CHEMOTAXIS OF IMMUNE CELLS
    Publication number: 20140294862
    Abstract: The current invention is directed to methods of inducing migration of an immune cell toward a cancer cell comprising inhibiting the activity of a chemorepellant released from the cancer cell.
    Type: Application
    Filed: March 20, 2014
    Publication date: October 2, 2014
    Applicant: Celtaxsys, Inc.
    Inventors: Surendra Chavan, Jonathan L. Moon, Lopa Bhatt
  • Methods of modulating the negative chemotaxis of immune cells
    Patent number: 8715654
    Abstract: The current invention is directed to methods of inducing migration of an immune cell toward a cancer cell comprising inhibiting the activity of a chemorepellant released from the cancer cell.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: May 6, 2014
    Assignee: Celtaxsys, Inc.
    Inventors: Surendra Chavan, Jonathan L. Moon, Lopa Bhatt
  • METHOD OF INDUCING NEGATIVE CHEMOTAXIS USING AN ELLAGITANNIN OR GALLOTANNIN
    Publication number: 20100129418
    Abstract: The current invention is directed to methods of inducing the negative chemotaxis of a migratory cell comprising contacting the cell with a compound selected from the group consisting of an ellagitannin and a gallotannin. In one embodiment, the compound is ellagic acid or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 18, 2009
    Publication date: May 27, 2010
    Inventors: Lowell Jeffry Lawrence, William Patrick Reddick, Surendra Chavan
  • METHODS OF MODULATING THE NEGATIVE CHEMOTAXIS OF IMMUNE CELLS
    Publication number: 20100104587
    Abstract: The current invention is directed to methods of inducing migration of an immune cell toward a cancer cell comprising inhibiting the activity of a chemorepellant released from the cancer cell.
    Type: Application
    Filed: October 2, 2009
    Publication date: April 29, 2010
    Inventors: Surendra Chavan, Jonathan L. Moon, Lopa Bhatt
  • Re-activated T-cells for adoptive immunotherapy
    Publication number: 20030170238
    Abstract: A method for increasing the cytokine production of T-cells intended for use in adoptive immunotherapy is provided. The method improves adoptive immunotherapy methods where the efficacy of the treatment is dependent, at least in part, on the amount of cytokine production from the cells. In practicing the method, ex-vivo produced T-cells intended for use in adoptive immunotherapy treatment protocols are allowed to rest after harvest and then are re-activated just prior to infusion.
    Type: Application
    Filed: September 17, 2002
    Publication date: September 11, 2003
    Inventors: Micheal L. Gruenberg, Surendra Chavan